" class="no-js "lang="en-US"> Acquisition Archives - Medtech Alert
Wednesday, April 10, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

Ironwood Pharmaceuticals, a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering […]

Sobi to Acquire CTI BioPharma

CTI BioPharma, a commercial biopharmaceutical company focused on the development and commercialization of novel targeted […]

Boston Scientific Closes Acquisition of Apollo Endosurgery

Boston Scientific today announced the close of its acquisition of Apollo Endosurgery, a publicly traded […]

Sumitovant Biopharma Completes Acquisition of Myovant Sciences

Sumitovant Biopharma and Myovant Sciences announced today that Sumitovant has successfully completed its acquisition of […]

Vistagen to Acquire Pherin Pharmaceuticals

Vistagen, a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more